New antibody drug aims to restore skin color in vitiligo patients
NCT ID NCT07223229
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 26 times
Summary
This study tests a new drug called EI-001 in 45 adults with nonsegmental vitiligo, a condition that causes white patches on the skin. The drug works by calming the immune system to reduce inflammation that leads to pigment loss. Participants will receive either EI-001 or a placebo to see if it safely improves skin color over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SEGMENTAL VITILIGO are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Linkou Chang Gung Memorial Hospital
RECRUITINGTaoyuan, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Skin Care Research, LLC
NOT_YET_RECRUITINGHollywood, Florida, 33021, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
U Mass Chan Medical School
WITHDRAWNWorcester, Massachusetts, 01605, United States
Conditions
Explore the condition pages connected to this study.